BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36951574)

  • 1. Structural Basis for Binding of Neutralizing Antibodies to
    Goldsmith JA; Dewar V; Hermand P; Blais N; McLellan JS
    J Bacteriol; 2023 Apr; 205(4):e0045622. PubMed ID: 36951574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytotoxic effect of Clostridioides difficile pore-forming toxin CDTb.
    Landenberger M; Nieland J; Roeder M; Nørgaard K; Papatheodorou P; Ernst K; Barth H
    Biochim Biophys Acta Biomembr; 2021 Jun; 1863(6):183603. PubMed ID: 33689753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the cell-binding component of the
    Xu X; Godoy-Ruiz R; Adipietro KA; Peralta C; Ben-Hail D; Varney KM; Cook ME; Roth BM; Wilder PT; Cleveland T; Grishaev A; Neu HM; Michel SLJ; Yu W; Beckett D; Rustandi RR; Lancaster C; Loughney JW; Kristopeit A; Christanti S; Olson JW; MacKerell AD; Georges AD; Pozharski E; Weber DJ
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1049-1058. PubMed ID: 31896582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Importance of Therapeutically Targeting the Binary Toxin from
    Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural elucidation of the
    Sheedlo MJ; Anderson DM; Thomas AK; Lacy DB
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6139-6144. PubMed ID: 32123082
    [No Abstract]   [Full Text] [Related]  

  • 6. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance.
    Gerding DN; Johnson S; Rupnik M; Aktories K
    Gut Microbes; 2014; 5(1):15-27. PubMed ID: 24253566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile binary toxin CDT induces clustering of the lipolysis-stimulated lipoprotein receptor into lipid rafts.
    Papatheodorou P; Hornuss D; Nölke T; Hemmasi S; Castonguay J; Picchianti M; Aktories K
    mBio; 2013 Apr; 4(3):e00244-13. PubMed ID: 23631918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
    Doosti A; Mokhtari-Farsani A
    Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Cook ME; Varney KM; Godoy-Ruiz R; Weber DJ
    Biomol NMR Assign; 2021 Apr; 15(1):35-39. PubMed ID: 33034833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and Pharmacological Inhibition of the Pore-Forming
    Ernst K; Landenberger M; Nieland J; Nørgaard K; Frick M; Fois G; Benz R; Barth H
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34071730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90.
    Kaiser E; Kroll C; Ernst K; Schwan C; Popoff M; Fischer G; Buchner J; Aktories K; Barth H
    Infect Immun; 2011 Oct; 79(10):3913-21. PubMed ID: 21768281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryo-EM structures of the translocational binary toxin complex CDTa-bound CDTb-pore from Clostridioides difficile.
    Kawamoto A; Yamada T; Yoshida T; Sato Y; Kato T; Tsuge H
    Nat Commun; 2022 Oct; 13(1):6119. PubMed ID: 36253419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neutralizing antibody that blocks delivery of the enzymatic cargo of
    Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
    J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile.
    Gonçalves C; Decré D; Barbut F; Burghoffer B; Petit JC
    J Clin Microbiol; 2004 May; 42(5):1933-9. PubMed ID: 15131151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a neutralizing antibody helps identify structural features critical for binding of
    Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
    J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional significance of active site residues in the enzymatic component of the
    Davies AH; McGlashan J; Posner MG; Roberts AK; Shone CC; Acharya KR
    Biochem Biophys Rep; 2016 Dec; 8():55-61. PubMed ID: 28955942
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural insights into the transition of Clostridioides difficile binary toxin from prepore to pore.
    Anderson DM; Sheedlo MJ; Jensen JL; Lacy DB
    Nat Microbiol; 2020 Jan; 5(1):102-107. PubMed ID: 31712627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for substrate recognition in the enzymatic component of ADP-ribosyltransferase toxin CDTa from Clostridium difficile.
    Sundriyal A; Roberts AK; Shone CC; Acharya KR
    J Biol Chem; 2009 Oct; 284(42):28713-9. PubMed ID: 19692332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored cyclodextrin pore blocker protects mammalian cells from clostridium difficile binary toxin CDT.
    Roeder M; Nestorovich EM; Karginov VA; Schwan C; Aktories K; Barth H
    Toxins (Basel); 2014 Jul; 6(7):2097-114. PubMed ID: 25029374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR).
    Hemmasi S; Czulkies BA; Schorch B; Veit A; Aktories K; Papatheodorou P
    J Biol Chem; 2015 May; 290(22):14031-44. PubMed ID: 25882847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.